Print Page    Close Window

SEC Filings

8-K
PROTALIX BIOTHERAPEUTICS, INC. filed this Form 8-K on 08/09/2018
Entire Document
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: August 9, 2018 PROTALIX BIOTHERAPEUTICS, INC.
   
   
  By: /s/ Moshe Manor               
   

Name: Moshe Manor

Title:   President and

            Chief Executive Officer